Temperatures are dropping and it’s time to give cough the cold shoulder. According to new findings from
, which were compiled by IMS Health using U.S. national and regional data on cold and flu trends, Philadelphia residents are now experiencing peak cold and flu season. Already this season,
the U.S. has experienced its earliest flu season in nearly 10 years with areas across the country having higher-than-normal flu rates
. In Philadelphia, more than one million adult residents have experienced troublesome cold and flu symptoms and nearly 918,000 have reported suffering from cough.
is a new interactive tool, available at
, that allows people to track cough activity in their local area so they can be prepared to effectively treat their symptoms and avoid the “COUGHequences™” such as missing out on work and social gatherings.
On average, there are more than
one billion cases of the common cold each year in the U.S.
and it is estimated that
between five and twenty percent of the population will get the flu
. Cough is a primary symptom of both the cold and the flu and
up to 50 percent of people suffering from a cold will have a cough
. Other cold and flu symptoms can include sore throat, nasal congestion and fever.
Robitussin® has reliably treated cold symptoms through a variety of different formulations tailored to fit different symptom combinations
, making for a more productive cold and flu season. For more information on Robitussin®, please visit
. To track cough activity, visit COUGHCAST™ at
Robitussin® COUGHCAST™ is a tool that tracks cough levels in areas across the country as the nation moves towards the peak of the season. U.S. national and regional data on cold and flu trends and market conditions reported by COUGHCAST™ were captured by IMS Health (
), a leading provider of information, services and technology for the healthcare industry around the world, on behalf of Pfizer Consumer Healthcare. COUGHCAST™ was designed to help consumers prepare for and manage symptoms as the season approaches peak weeks of respiratory activity. All data in this report is accurate as of January 5, 2013.
Media should contact Ronna Waldman at Marina Maher Communications, LLC(212) 485-6907/
for additional information